|
| |
Thomas Loew, MD
Research Profile
Contact Information:
Office Tel: (319) 356-2437
E-mail: thomas-loew@uiowa.edu
Education and Training:
Predoctoral and Doctoral Education
1972-77 BA, History, University of Virginia, Charlottesville, VA
Fall, 1977, Non-degree graduate work, Old Dominion University, Norfolk, VA
Fall, 1979, Non-degree graduate work, Old Dominion University, Norfolk, VA
1981-85 MD, St. George's University School of Medicine, Grenada, West Indies
Postgraduate Medical Education
1985-88, Pediatric Residency, UMDNJ - Robert Wood Johnson, New Brunswick, NJ
1987-88, Chief Resident, UMDNJ - Robert Wood Johnson, New Brunswick, NJ
1988-91, Subspecialty Training, Columbia University, College of Physicians and Surgeons, New York, NY
Research Interests:
My primary research interests are in the clinical arena. These include clinical oncologic protocols sponsored by the Children’s Oncology Group, enzyme replacement therapy for individuals with storage diseases, and pharmaceutical drug trials with such companies as Amgen, Novartis and Genzyme. In addition, I am participating in an ongoing study of the effects of governmental regulations of Medicare/Medicaid documentation and their effects upon academic teaching faculty.
|
|
Affiliations:
Model System:
Recent Publications:
- Wilcox CL, Bechensteen AG, Rebouche CJ, Widness JA, (Intr. by Loew TW). Laboratory parameters and liver iron stores - what provides the best estimate of body iron in the neonatal period? 45th American Society of Hematology Meeting, Orlando, FL, December 6-10, 2003.
- Loew TW, Gamis A, Smith O, Massey GV, Woods WG, Hilden JM, Lange B, Alonzo TA, Change M, Gerbing RB. Down Syndrome Patients with Relapsed Acute Myelogenous leukemia. 46th American Society of Hematology Meeting, San Diego, CA, December 4-7, 2004.
- Loew TW, Gamis A. Smith O, Massey GV, Woods WG, Hilden JM, Lange B, Alonzo TA, Change M, Gerbing RB. Induction Therapy Failures in Down Syndrome Patients with Acute Myelogenous Leukemia. 46th American Society of Hematology Meeting, San Diego, CA, December 4-7, 2004.
- Blumer JL, Berg S, Adamson P, Hastings C, Loew TW, Colowick A. Darbepoetin alfa for the treatment of anemia in pediatric patients with non-myeloid malignancies receiving chemotherapy: A phase I, open-label pharmacokinetic study. 18th American Society of Pediatric Hematology/Oncology Meeting. Washington, D.C., May 13-16, 2005.
|
|
